Livzon Pharmaceutical Group Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Livzon Pharmaceutical Group Stock Forecast and Price Target
Livzon Pharmaceutical Group's stock is projected to advance by 11.41% from the previous closing price if it reaches the average target of ¥41.20 by the year's end, as reputable analysts recently projected. This potential upside is calculated on a high-end estimate of ¥47.50 and a low-end estimate of ¥31.00. If you are interested in 000513 stock, it is important to also consider its competitors.
11.41% Upside
Livzon Pharmaceutical Group Fair Value Forecast for 2023 - 2025 - 2030
In the last zero years, Livzon Pharmaceutical Group's Price has seen an increase, rising from ¥0.00 to ¥0.00. This represents a growth of 100.00%. Analysts predict that Livzon Pharmaceutical Group's Fair Value will increase in the upcoming year, reaching ¥36.00. This would represent an increase of 100.00%. Over the next seven years, experts predict that Livzon Pharmaceutical Group's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600276 Stock Forecast | Jiangsu Hengrui Medicine | Buy |
15
|
¥46.16 | Buy/Sell | ¥56.49 | 16.98% |
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF514.00 | Buy/Sell | CHF516.89 | 15.76% |
| 603259 Stock Forecast | WuXi AppTec | Buy |
18
|
¥43.67 | Buy/Sell | ¥121.48 | 49.21% |
| 601607 Stock Forecast | Shanghai Pharmaceuticals Holdi... | Outperform |
18
|
¥17.92 | Buy/Sell | ¥20.67 | 22.77% |
| 000999 Stock Forecast | China Resources Sanjiu Medical... | Buy |
18
|
¥59.97 | Buy/Sell | ¥65.95 | 13.62% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 000963 Stock Forecast | Huadong Medicine | Buy |
18
|
¥32.94 | Buy/Sell | ¥52.40 | 34.34% |
| 600196 Stock Forecast | Shanghai Fosun Pharmaceutical ... | Outperform |
16
|
¥23.67 | Buy/Sell | ¥33.57 | 20.83% |
| 874 Stock Forecast | Guangzhou Baiyunshan Pharmaceu... | Outperform |
16
|
HK$21.90 | Buy/Sell | HK$24.33 | 4.34% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600079 Stock Forecast | Humanwell Healthcare (Group) | Buy |
0
|
¥20.25 | Buy/Sell | ¥32.49 | -100.00% |
| 603707 Stock Forecast | Nanjing King-Friend Biochemica... | Buy |
16
|
¥13.91 | Buy/Sell | ¥20.19 | 45.15% |
| 603456 Stock Forecast | Zhejiang Jiuzhou Pharmaceutica... | Buy |
18
|
¥16.12 | Buy/Sell | ¥37.79 | 46.46% |
Livzon Pharmaceutical Group EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last zero years, Livzon Pharmaceutical Group's EPS has seen an increase, rising from ¥0.00 to ¥0.00. This represents a growth of 100.00%. Analysts predict that Livzon Pharmaceutical Group's EPS will increase in the upcoming year, reaching ¥2.40. This would represent an increase of 100.00%. Over the next seven years, experts predict that Livzon Pharmaceutical Group's EPS will grow at a rate of 100.00%.
Site Navigation
.jpg)